Camila R. Fontes-Garfias

Author

The University of Texas Medical Branch at Galveston ORCID

Also Known As

Camila Fontes-Garfias, Camila R Fontes-Garfias, Camila R. Fontes, Camila R. Fontes-Garfias, Fontes-Garfias, Camila

Publications

13.8K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Medical Branch at Galveston Pfizer (United States)BioNTech (Germany)Johannes Gutenberg University Mainz Clinical Research Services

About

Camila R. Fontes-Garfias is an author at The University of Texas Medical Branch at Galveston specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	6.8K
2	Immunology	13	13	4.8K
3	Allergy	1	1	810
4	Cell Biology	1	1	191
5	Epidemiology	1	1	123

Camila R. Fontes-Garfias

Publications

13K

Citations

H-Index

Page 1

	Year	Citations
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates Edward E. Walsh, Robert W. Frenck, Ann R. Falsey, New England Journal of Medicine	2020	2.7K
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses Uğur Şahin, Alexander Muik, Evelyna Derhovanessian, Nature VaccinologyVaccinationVaccine DevelopmentHuman AntibodyImmunology	2020	2K
Spike mutation D614G alters SARS-CoV-2 fitness Jessica A. Plante, Yang Liu, Jianying Liu, Nature Viral EvolutionViral PathogenesisVirologyViral Structural ProteinSystems Biology	2020	1.7K
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin, Nature	2020	1.6K
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans Uğur Şahin, Alexander Muik, Isabel Vogler, Nature VaccinationBnt162b2 Vaccine InducesAllergyImmunologyTherapeutic Vaccine	2021	810
BNT162b vaccines protect rhesus macaques from SARS-CoV-2 Annette B. Vogel, Isis Kanevsky, Ye Che, Nature VaccinationBnt162b VaccinesVaccine DevelopmentVaccine TargetImmunology	2021	725
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera Xuping Xie, Yang Liu, Jianying Liu, Nature Medicine	2021	670
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation Antonio E. Muruato, Camila R. Fontes-Garfias, Ping Ren, Nature Communications VaccinationVaccine DevelopmentViral DiagnosticsVaccine SurveillanceFluorescence-based Neutralization Assay	2020	329
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease Justin M. Richner, Brett W. Jagger, Chao Shan, Cell VaccinationVaccinologyMaternal ImmunizationVaccine DevelopmentImmunology	2017	264
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 Xuping Xie, Antonio E. Muruato, Xianwen Zhang, Nature Communications	2020	235

Page 1